Vertex Pharmaceuticals recently announced important updates on its investigational kidney disease therapy povetacicept, including FDA regulatory progress and upcoming data presentations, as well as ...
Vertex Pharmaceuticals Incorporated today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company's most recently ...
Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...
Global equity markets rose 7.7%, led by AI-related stocks in the Information Technology and Communications Services sectors.
Viking Holdings Ltd (NYSE:VIK) is one of the stocks Jim Cramer recently highlighted. Cramer discussed the company’s stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback